The nation is on the cusp of a second vaccine for COVID-19, with independent federal advisers voting in favor Thursday on Moderna’s two-shot vaccine.
Panel recommends Moderna vaccine, paving way for FDA authorization
The nation is on the cusp of a second vaccine for COVID-19, with independent federal advisers voting in favor Thursday on Moderna’s two-shot vaccine.